The INCORRECT Answer is B: Endoscopic evaluation of the upper and lower gastrointestinal tract is necessary
In this 27-year-old woman with classic IBS symptoms and no alarm features (no weight loss, no iron-deficiency anemia), routine endoscopic evaluation is NOT necessary and should be avoided. 1
Why Endoscopy is NOT Indicated Here
The 2023 Nature Reviews Gastroenterology and Hepatology guidelines explicitly state that "limited investigations (for example, coeliac serology) are needed in all patients with suspected IBS, but exhaustive investigation should be avoided. The focus should be on making an early diagnosis of IBS to facilitate early initiation of treatment" 1.
This patient has:
- No alarm features (no weight loss, no anemia, young age)
- Classic IBS symptoms (chronic abdominal pain, alternating bowel habits, bloating)
- Psychological comorbidity (anxiety, depression) which is present in 39% of IBS patients 1
Gastroenterologist referral is only indicated "if the diagnosis of IBS is in doubt and symptoms have proven refractory to treatment in primary care" 1. This patient hasn't even started treatment yet.
Why the Other Options ARE Correct
A) Dietary Modification - CORRECT
Avoidance of trigger foods is appropriate first-line management. Patient-centered dietary counseling should be tailored to the individual 1. For moderate-to-severe GI symptoms, a low FODMAP diet delivered by a dietitian is effective 1, though given her prominent anxiety/depression, a gentle FODMAP or Mediterranean diet approach may be more appropriate 1.
C) Antispasmodics - CORRECT
Empiric antispasmodic use is appropriate for abdominal pain relief. The British Society of Gastroenterology confirms "various antispasmodics can be given to reduce pain, those with an anticholinergic action appearing to be slightly more effective" 2.
D) Tricyclic Antidepressants - CORRECT
TCAs are explicitly recommended as second-line treatment for IBS, particularly for pain 1. The 2023 guidelines state: "Low-dose tricyclic antidepressants (TCAs) are preferred for gastrointestinal symptoms, particularly pain" 1. TCAs showed global symptom relief (RR 0.67) and abdominal pain relief (RR 0.76-0.94) 3. Given her anxiety and depression, if a mood disorder is present, an SSRI at therapeutic doses might be preferred over low-dose TCAs 1.
E) Rifaximin - CORRECT
Non-absorbable antibiotics like rifaximin are appropriate empiric therapy, particularly for IBS with bloating and diarrhea 4. While not first-line, rifaximin is a recognized treatment option in modern IBS management.
Critical Pitfall to Avoid
The major pitfall here is over-investigating young patients with classic IBS symptoms and no red flags. This delays diagnosis, increases patient anxiety, wastes healthcare resources, and can reinforce illness behavior 1. The appropriate investigations are limited: full blood count, C-reactive protein, and coeliac serology 5. Endoscopy should be reserved for patients with alarm features or refractory symptoms after appropriate treatment trials.